Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

China flag China · Delayed Price · Currency is CNY
22.96
+0.67 (3.01%)
Apr 28, 2026, 3:00 PM CST
-11.69%
Market Cap 35.48B
Revenue (ttm) 78.46B
Net Income (ttm) 2.95B
Shares Out 1.63B
EPS (ttm) 1.81
PE Ratio 12.67
Forward PE 11.90
Dividend 0.90 (4.04%)
Ex-Dividend Date n/a
Volume 23,276,876
Average Volume 9,924,550
Open 22.64
Previous Close 22.29
Day's Range 22.64 - 23.16
52-Week Range 22.28 - 27.85
Beta 0.35
RSI 45.70
Earnings Date Apr 27, 2026

About SHA:600332

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, productio... [Read more]

Sector Healthcare
Founded 1997
Employees 27,057
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600332
Full Company Profile

Financial Performance

In 2025, SHA:600332's revenue was 77.66 billion, an increase of 3.55% compared to the previous year's 74.99 billion. Earnings were 2.98 billion, an increase of 5.21%.

Financial Statements

News

There is no news available yet.